Table 2.
Genes symbol | Nucleotide sequence of primers (5'−3') | Product size | Accession |
---|---|---|---|
β-actin | F: GGCGCCCAGCACGAT | 66 | XM_021086047.1 |
R: CCGATCCACACGGAGTACTTG | |||
GPR41 | F: TCTTCACCACCGTCTATCTCAC | 398 | NM_001315601.1 |
R: CACAAGTCCTGCCACCCTC | |||
GPR43 | F: CTGCCTGGGATCGTCTGTG | 249 | XM_021093196.1 |
R: CATACCCTCGGCCTTCTGG | |||
Caspase3 | F: TCTAAGCCATGGTGAAGAAGGAAAAA | 112 | NM_214131.1 |
R: GGGTTTGCCAGTTAGAGTTCTACAG | |||
IL-10 | F: CACGGCCTTGCTCTTGTTTT | 148 | NM_214041.1 |
R: CCTGGAAGACGTAATGCCGA | |||
TGF-β | F: CTGACCCGCAGAGAGGCTAT | 102 | NM_214015.2 |
R: AGAATTGAACCCGTTAATTTCCACG | |||
Bax | F: TGACGGCAACTTCAACTGGG | 143 | XM_013998624.2 |
R: GCAGCCGATCTCGAAGGAAGT | |||
Bcl2 | F: GAGGATTGTGGCCTTCTTTGAGT | 155 | XM_021099593.1 |
R: CATCCCAGCCTCCGTTATCC | |||
Foxp3 | F: TCAGACCAACAGGGAGCCAA | 88 | XM_021079539.1 |
R: TCAAGGAGGAAGAGGAGGCG | |||
HDAC9 | F: CAACAGAACGGATGGGGTGG | 128 | XM_021102511.1 |
R: GGTCTAAAGGCGAGATGGGC | |||
NLRP3 | F: GGAGGAGGAGGAAGAGGAGATA | 147 | NM_001256770.2 |
R: AGGACTGAGAAGATGCCACTAC | |||
IL18 | F: AGTAACCATCTCTGTGCAGTGT | 155 | NM_213997.1 |
R: TCTTATCATCATGTCCAGGAAC | |||
Caspase1 | F: GAAGGAGAAGAGGAGGCTGTT | 268 | NM_214162.1 |
R: AGATTGTGAACCTGTGGAGAGT | |||
ASC | F: ACAACAAACCAGCACTGCAC | 126 | XM_003124468.5 |
R: CTGCCTGGTACTGCTCTTCC | |||
IL1β | F: TCTGCCCTGTACCCCAACTG | 64 | XM_021085847.1 |
R: CCAGGAAGACGGGCTTTTG |
F, forward primer sequence (5′ → 3′); R, reverse primer sequence (5′ → 3′).
Gene: GPR41, G protein-coupled receptor 41; GPR43, G protein-coupled receptor 43; Caspase3, Cysteine-requiring aspartate protease 3; IL 10, Interleukin 10; TGF-β, transforming growth factor-β; Bax, BCL2-Associated X; Bcl2, B cell lymphoma 2; Foxp3, Forkhead box P3; HDAC9, Histone deacetylase 9; NLRP3, Nod-like receptor, pyrin domain 3 containing; IL 18, Interleukin 18; Caspase1, Cysteine-requiring aspartate protease 1; ASC, Apoptosis-associated speck-like protein containing CARD; IL-1β, Interleukin 1β.